Maravai LifeSciences Holdings, Inc. MRVI Cygnus — Other Restructuring Costs
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherRestructuringCosts.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s cygnus — other restructuring costs.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s cygnus — other restructuring costs?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — other restructuring costs of $0 in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s cygnus — other restructuring costs changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s cygnus — other restructuring costs decreased by 100.0% year-over-year, from $750 to $0.
- What does cygnus — other restructuring costs mean?
- Encompasses miscellaneous expenses directly attributable to restructuring initiatives within the Biologics Safety Testing segment, excluding direct severance. These costs may include facility closures, contract terminations, or relocation expenses. It provides transparency into the total financial burden associated with strategic business realignments.